{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieslwgwqjgkcuhevnm3qgvgygyjxad7kccfdue2n7gma2yqfp7uvu",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mo2k3nh4hmy2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidwdwl7nqhzoz536uh4fpeunj4qdapybp7kss6fa2gh4rp4g2aqti"
    },
    "mimeType": "image/jpeg",
    "size": 101377
  },
  "path": "/news/2026-06-treatment-patients-rare-blood-disorder.html",
  "publishedAt": "2026-06-11T20:00:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new treatment that involves growing a patient's immune cells and then infusing them back into their body has shown promise for people with the rare blood disorder aplastic anemia. Results from the Phase 1 trial, led by Professor Ghulam Mufti, provide the first evidence that autologous regulatory T-cell therapy is feasible and safe in people with aplastic anemia and may have clinical benefit.",
  "title": "New treatment shows promise for patients with rare blood disorder"
}